Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
about
Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.Diagnostic accuracy of ELISA for detecting serum Midkine in cancer patients.Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy.Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies.Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelinSerum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.Midkine's Role in Cardiac Pathology.Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study.A multiplex platform for the identification of ovarian cancer biomarkersSerum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myelomaMidkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
P2860
Q33779147-E118CB16-AA49-4826-B05F-9E8B93A74087Q33884098-BEF1055D-BF92-4F96-85B8-85A578058597Q35402367-57B9CC55-438E-4B45-B21A-B251543EB5ADQ35992637-B63B2311-7417-493C-85EC-5A1BE07A6188Q36320997-6C339392-0254-417F-9EA6-A09EE7BEE290Q36706828-1B4388A7-2531-4C07-93C2-6B141CB49948Q37406847-981206FF-5EF2-4422-9FB1-EA1A2C43C6ECQ37736235-76D72B5B-FA0E-446A-B37B-678BBA96513BQ38704616-8A74D203-8B3F-442D-BE53-BAF73A96C609Q41066331-50B534A4-30FA-4F14-9C39-68D2DF82F2D8Q42368625-19A5B577-F256-4651-BA2C-5BBF06545D24Q42374131-402C4197-6323-434D-9DD2-D7DD9A89D94DQ42378344-46CDFC3F-7A05-4BE9-9554-A9619A4C973DQ47159539-2CC14688-9BB6-4FB2-BEC4-A869E92317F0Q55110685-32A3F9D9-F327-4CFE-8322-A449323A5031Q58759151-EB40062D-7194-4EFE-B070-01468D27C9F0
P2860
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
@en
type
label
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
@en
prefLabel
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
@en
P2860
P356
P1476
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
@en
P2093
P2860
P304
P356
10.1111/BPH.12601
P407
P577
2014-06-01T00:00:00Z